CGT-2168: Phase III start

This quarter, Cogentus will begin a double-blind, international Phase III trial in 3,200 patients to evaluate aspirin plus CGT-2168 or Plavix clopidogrel from Bristol-Myers Squibb Co. (BMY, New York...